Belinostat；866323-14-0；Belinostat Formula： C15H14N2O4S

Formula:C15H14N2O4S

Molecular Weight：318.35

Appearance：Off-white crystalline powder

Purity：98+%

Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity. Belinostat targets HDAC enzymes, thereby inhibiting tumor cell proliferation, inducing apoptosis, promoting cellular differentiation, and inhibiting angiogenesis. This agent may sensitize drug-resistant tumor cells to other antineoplastic agents, possibly through a mechanism involving the down-regulation of thymidylate synthase.